In this episode, we are excited to have Linda Elsegood, an advocate and expert in the field of low-dose naltrexone (LDN). LDN has gained significant attention in recent years for its potential in treating a wide range of conditions, from autoimmune diseases to chronic pain. In this episode, we'll dive into the world of LDN, exploring its mechanism of action, its applications across various health conditions, and the transformative experiences of individuals who have incorporated LDN into their treatment protocols. Linda Elsegood is an esteemed voice in the LDN community, having founded the LDN Research Trust. She will share her wealth of knowledge and personal experiences, discussing the science behind LDN, its safety profile, and the ongoing research that continues to expand our understanding of its potential benefits. If you've ever been curious about LDN or are seeking alternative treatment options for your health condition, join us for this captivating conversation with Linda Elsegood on low dose naltrexone.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related